XML 1055 R42.htm IDEA: XBRL DOCUMENT
v3.8.0.1

COMMITMENTS AND CONTINGENCIES (Details Narrative) |  |  | 1 Months Ended | 3 Months Ended | 4 Months Ended | 9 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | ---
Aug. 08, 2017 | Oct. 02, 2016 USD ($) shares | May 31, 2017 EUR (€) | Oct. 25, 2016 USD ($) | Jun. 30, 2016 USD ($) | May 31, 2016 USD ($) | Dec. 31, 2015 USD ($) | Jan. 31, 2015 USD ($) | Sep. 30, 2014 USD ($) | Aug. 31, 2012 USD ($) | Sep. 30, 2017 USD ($) shares | Sep. 30, 2016 USD ($) | Sep. 30, 2016 USD ($) | Sep. 30, 2017 USD ($) shares | Sep. 30, 2016 USD ($) | Dec. 31, 2016 USD ($) | Dec. 31, 2015 USD ($) | Jun. 21, 2016 USD ($)
Operating lease periodic payment |  |  |  |  |  |  |  | $ 730 |  |  |  |  | $ 709 |  |  |  |  |
Frequency of periodic payment |  |  |  |  |  |  |  | Monthly |  |  |  |  | Monthly |  |  |  |  |
Operating lease rental expense |  |  |  |  |  |  |  |  |  |  | $ 2,126 | $ 2,126 |  | $ 6,377 | $ 2,834 | $ 4,960 | $ 12,053 |
Operating lease expiration date |  |  |  |  |  |  |  | Nov. 30, 2015 |  |  |  |  |  |  |  |  |  |
Decahedron [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Operating lease periodic payment |  |  |  | $ 2,415 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Operating lease rental expense |  |  |  |  |  |  |  |  |  |  |  |  |  | 19,580 |  |  |  |
Term of operating lease |  |  |  | 1 year |  |  |  |  |  |  |  |  |  |  |  |  |  |
Private Placement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Commitments and contingencies description | (1) a cash commission of 6% of the total gross proceeds for two named investors (2) a cash commission of 4% of total gross proceeds from five named investors and (3) excluding the five named investors in “(2)” a cash commission equal to 8% of the total gross proceeds from the Offering and the issuance to the Agent or its designees of warrants covering 8% of the shares of common stock issued or issuable by the Company in the Offering. Additionally, the Agent will receive a cash fee of 8% payable within 5 business days, but only in the event of, the receipt by the Company of any cash proceeds from the exercise of any warrants with an expiration equal to or less than 24 months sold in the Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amplerissimo [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Operating lease periodic payment |  |  |  |  |  |  |  |  |  | $ 122 |  |  |  |  |  |  |  |
Frequency of periodic payment |  |  |  |  |  |  |  |  |  | Monthly |  |  |  |  |  |  |  |
Operating lease rental expense |  |  |  |  |  |  |  |  |  |  | 368 | 368 |  | 1,105 | 1,103 | 1,462 | 1,462 |
Operating lease expiration date |  |  |  |  |  |  |  |  |  | Jul. 31, 2013 |  |  |  |  |  |  |  |
Operating lease renewal date |  |  |  |  |  |  |  |  |  | Jul. 31, 2015 |  |  |  |  |  |  |  |
SkyPharm [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Operating lease periodic payment |  |  | € 1,250 |  |  |  |  |  | $ 4,802 |  |  |  |  |  |  |  |  |
Operating lease rental expense |  |  |  |  |  |  |  |  |  |  | $ 30,094 | $ 25,961 |  | 84,710 | 64,127 | $ 89,323 | $ 60,614 |
Term of operating lease |  |  |  |  |  |  |  |  | 6 years |  |  |  |  |  |  |  |  |
SkyPharm [Member] | Additional space [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Operating lease periodic payment |  |  |  |  | $ 2,021 | $ 886 |  |  |  |  |  |  |  |  |  |  |  |
SkyPharm [Member] | First Floor [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Operating lease periodic payment |  |  |  |  |  |  | $ 886 |  |  |  |  |  |  |  |  |  |  |
Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Operating lease periodic payment |  | $ 1,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved | shares |  | 200,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | Conclusion of Phase III testing [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved | shares |  | 50,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | Conclusion of Phase II testing [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved | shares |  | 50,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | conclusion of Phase I testing [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved | shares |  | 50,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | Conclusion of Preclinical Trials [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved | shares |  | 50,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | On October 1, 2016 [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Operating lease periodic payment |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,500 |  |  |  |
Common stock shares reserved | shares |  |  |  |  |  |  |  |  |  |  | 200,000 |  |  | 200,000 |  |  |  |
Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | On October 1, 2016 [Member] | Conclusion of Phase III testing [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved | shares |  |  |  |  |  |  |  |  |  |  | 50,000 |  |  | 50,000 |  |  |  |
Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | On October 1, 2016 [Member] | Conclusion of Phase II testing [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved | shares |  |  |  |  |  |  |  |  |  |  | 50,000 |  |  | 50,000 |  |  |  |
Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | On October 1, 2016 [Member] | conclusion of Phase I testing [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved | shares |  |  |  |  |  |  |  |  |  |  | 50,000 |  |  | 50,000 |  |  |  |
Anastasios Tsekas and Olga Parthenea Georgatsou [Member] | Intellectual property sale agreement [Member] | On October 1, 2016 [Member] | Conclusion of Preclinical Trials [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved | shares |  |  |  |  |  |  |  |  |  |  | 50,000 |  |  | 50,000 |  |  |  |
CC Pharma GmbH [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Non-refundable fee |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 454,800
Expense paid |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 454,800 |  |  |

X
- References No definition available. + Details
Name: | COSM_AmendmentToMaturityDate
Namespace Prefix: | COSM_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | COSM_FrequencyOfPeriodicPayment
Namespace Prefix: | COSM_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | COSM_NonrefundableFee
Namespace Prefix: | COSM_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References No definition available. + Details
Name: | COSM_OperatingLeasePeriodicPayment
Namespace Prefix: | COSM_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Describes all significant commitments and obligations resulting from franchise agreements, including a description of the services that the franchisor has agreed to provide for agreements that have not yet been substantially performed. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 952 -SubTopic 440 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6490765&loc=d3e67606-108037 + Details
Name: | us-gaap_CommitmentsFromFranchiseAgreements
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Aggregate number of common shares reserved for future issuance. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total costs of sales and operating expenses for the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_CostsAndExpenses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Date which lease or group of leases is set to expire, in CCYY-MM-DD format. + References No definition available. + Details
Name: | us-gaap_LeaseExpirationDate1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Term of the lessee's leasing arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41499-112717 + Details
Name: | us-gaap_OperatingLeasesRentExpenseNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=COSM_DecahedronMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AmplerissimoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_SkyPharmMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LeaseArrangementTypeAxis=COSM_AdditionalSpaceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LeaseArrangementTypeAxis=COSM_FirstFloorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_AnastasiosTsekasAndOlgaPartheneaGeorgatwouMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=COSM_IntellectualPropertySaleAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LeaseArrangementTypeAxis=COSM_ConclusionOfPhaseThreeTestingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LeaseArrangementTypeAxis=COSM_ConclusionOfPhaseTwoTestingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LeaseArrangementTypeAxis=COSM_ConclusionOfPhaseOneTestingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LeaseArrangementTypeAxis=COSM_ConclusionOfPreclinicalTrialsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CreationDateAxis=COSM_OnOctoberOneTwoThousandSixteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=COSM_CCPharmaGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |